Research ArticleOriginal Article
Open Access
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia
Abrar Ashi, Marwan Al-Hajeili, Sarah Almaghrabi, Jaudah Al-Maghrabi, Nora Trabulsi, Shmoukh Alghuraibi, Rawaih Alsiary and Nuha Alrayes
Saudi Medical Journal June 2024, 45 (6) 565-571; DOI: https://doi.org/10.15537/smj.2024.45.6.20230878
Abrar Ashi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhDMarwan Al-Hajeili
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
MD, MSSarah Almaghrabi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhDJaudah Al-Maghrabi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
MD, FRCPCNora Trabulsi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
FRCSCShmoukh Alghuraibi
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
MScRawaih Alsiary
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhDNuha Alrayes
From the Department of Medical Laboratory Sciences (Ashi, Almaghrabi, Alrayes), Faculty of Applied Medical Sciences; from the Regenerative Medicine Unit (Ashi), King Fahd Medical Research Center; from the Center of Innovations in Personalized Medicine (Almaghrabi); from the Department of Medicine (Al-Hajeili); from the Department of Pathology (Al-Maghrabi); from the Department of Surgery (Trabulsi), Faculty of Medicine, King Abdulaziz University, from King Abdullah International Medical Research Centre (Alsiary), King Saud bin Abdulaziz University for Health Sciences, and from the Research and Development Unit (Alghuraibi), Al Borg Medical Laboratories, Al Borg Diagnostics, Jeddah, Kingdom of Saudi Arabia.
PhD
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia
Abrar Ashi, Marwan Al-Hajeili, Sarah Almaghrabi, Jaudah Al-Maghrabi, Nora Trabulsi, Shmoukh Alghuraibi, Rawaih Alsiary, Nuha Alrayes
Saudi Medical Journal Jun 2024, 45 (6) 565-571; DOI: 10.15537/smj.2024.45.6.20230878
Prevalence of CEA, CA 125, and CA 15-3 serum tumour markers in different regions of Saudi Arabia
Abrar Ashi, Marwan Al-Hajeili, Sarah Almaghrabi, Jaudah Al-Maghrabi, Nora Trabulsi, Shmoukh Alghuraibi, Rawaih Alsiary, Nuha Alrayes
Saudi Medical Journal Jun 2024, 45 (6) 565-571; DOI: 10.15537/smj.2024.45.6.20230878
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.